Higher Nicotine Pouch Use Among US Soldiers Revealed

Jan.13.2025
Higher Nicotine Pouch Use Among US Soldiers Revealed
A new study by 29News on Jan 9 shows US soldiers are ten times more likely to use nicotine pouches like ZYN than civilians.

According to a report from 29News on January 9th, a recent study has shown that American soldiers are ten times more likely to use nicotine pouches like ZYN compared to the general population.


A survey conducted at the largest military base in the United States, Fort Bragg, found that 23.8% of service members reported using nicotine pouches at least once in the past 10 days. In contrast, a study of American adults in 2022 found that only 2.9% had used them in the same time period.


The study's co-author, Melissa Little, director of the Nicotine and Tobacco Research Center at the University of Virginia, pointed out that these nicotine pouches are not regulated by the FDA like tobacco products. While some believe that synthetic nicotine may be safer than tobacco, doctors warn that it is too early to draw any conclusions.


Littrell stated that addiction is more common among young and white male soldiers. Despite nicotine and tobacco use historically being a part of military culture, these nicotine pouches are particularly difficult to regulate.


Unlike cigarettes, soldiers can use these nicotine pouches anytime in the field and during training. Littrell says she is not against soldiers choosing to use nicotine pouches, but she hopes they can fully understand the health information and potential risks. She points out that it will take time to determine the specific extent of these risks.


For public health professionals, solving this issue will be particularly challenging, especially among young people and military personnel.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai
U.S. FDA posts TPSAC meeting materials ahead of discussion on ZYN MRTP applications
U.S. FDA posts TPSAC meeting materials ahead of discussion on ZYN MRTP applications
On January 20, 2026, the U.S. Food and Drug Administration (FDA) posted meeting materials ahead of a virtual Tobacco Products Scientific Advisory Committee (TPSAC) meeting scheduled for January 22, 2026, to discuss modified risk tobacco product (MRTP) applications submitted by Swedish Match USA, Inc. for 20 ZYN nicotine pouch products.
Jan.21 by 2FIRSTS.ai
UK South East Seized 3.1M Illegal Vapes Since 2021 as Crackdown Intensifies
UK South East Seized 3.1M Illegal Vapes Since 2021 as Crackdown Intensifies
Illegal vape seizures in the UK South East have risen sharply over the past five years, with 2023 marking the high point. While single-use vapes were banned from sale in June 2025, enforcement teams say disposable products remain in circulation, fueling renewed calls for licensing and stronger enforcement funding.
Jan.23 by 2FIRSTS.ai
Kansas, U.S.: Attorney General issues alert on China-made “smart vapes” targeting children
Kansas, U.S.: Attorney General issues alert on China-made “smart vapes” targeting children
On Jan. 10, Kansas Attorney General Kris Kobach issued a consumer alert warning Kansans about dangerous vaping products from China marketed as “smart vapes.” The alert says these devices let children use games, social media, Bluetooth, music and more while simultaneously inhaling unregulated materials, and describes them as designed to entice teens and conceal their nature from parents.
Jan.12 by 2FIRSTS.ai
Altria Reports Full-Year 2025 Results: Revenue Down 3.1%, Cigarette Volumes Slide 10% as NJOY Takes Impairment Hit
Altria Reports Full-Year 2025 Results: Revenue Down 3.1%, Cigarette Volumes Slide 10% as NJOY Takes Impairment Hit
Altria has released its full-year 2025 results, reporting full-year net revenues of $23.279 billion, down 3.1% year over year. Domestic cigarette shipment volume fell 10% for the year. on! nicotine pouches reached a 7.7% share of the U.S. oral tobacco category in the fourth quarter. NJOY posted $21 million in net revenues in Q4, while full-year net revenues were negative $13 million (mainly due to returns and related factors).
Jan.30 by 2FIRSTS.ai
Nicaragua’s Health Ministry reaffirms Resolution No. 334-2021, maintaining a total ban on vaping and e-cigarette sales
Nicaragua’s Health Ministry reaffirms Resolution No. 334-2021, maintaining a total ban on vaping and e-cigarette sales
Nicaragua’s Ministry of Health (MINSA) issued an official statement on January 2, 2026 reaffirming the validity of Ministerial Resolution No. 334-2021, which absolutely bans the use and commercialization of electronic nicotine delivery systems known as “vapeadores” or e-cigarettes.
Jan.04 by 2FIRSTS.ai